ARVN ranks #3013 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.
ARVN is a disclosed holding of David Shaw (D. E. Shaw & Co.), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.
ARVN is a top-conviction position for Pfizer Inc — at 16.2% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.
The largest dollar stake in ARVN belongs to BlackRock, Inc., but the position matters far more to Pfizer Inc, who has 16.2% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.
Essential Partners LLC has trimmed its ARVN position for two straight quarters, cutting it by $8.3K while still holding $12.0K.
ARVN is down 2.7% today, but institutions show net buying of $56.2M this quarter — a divergence between today's price move and the underlying institutional flow.